中华医学杂志（英文版）2024，Vol.137Issue(4)：487-489,3.DOI:10.1097/CM9.0000000000002862
An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer
An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer
Cong Li 1Fengzhu Guo 2Jingtong Zhai 3Xiaohan Liu 4Zhijun Li 3Binghe Xu3
作者信息
- 1. Department of Medical Oncology,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China||Department of Medical Oncology,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,China
- 2. Department of Medical Oncology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China
- 3. Department of Medical Oncology,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
- 4. Department of Histology and Embryology,Basic Medical College,China Medical University,Shenyang,Liaoning 110122,China
- 折叠
引用本文复制引用
Cong Li,Fengzhu Guo,Jingtong Zhai,Xiaohan Liu,Zhijun Li,Binghe Xu..An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer[J].中华医学杂志（英文版）,2024,137(4):487-489,3.
